Cervical cancer

Meet two of the latest Primer Awardees and find out why forensic science and nanomaterials are, in fact, ideal backgrounds for cancer research

We want to have a conversation about human papillomavirus (HPV), starting with 6 questions about HPV people frequently ask our Cancer Research UK nurses.

Dr Alison Berner and team asked 140 trans men and non-binary people to share their past experiences and attitudes towards cervical screening.

Last year, the World Health Organisation (WHO) announced their plans to create a global strategy to accelerate the elimination of cervical cancer as a public health problem.

Long awaited study results have confirmed that the quadrivalent human papillomavirus (HPV) vaccine substantially reduces invasive cervical cancer risk.  

Cervical cancer rates in Britain halved between the late 1980s and mid-2000s – but new CRUK figures warn that progress has since been stalling and stagnating.

The social stigmas and myths surrounding the human papilloma virus (HPV) could make women anxious, putting them off cervical screening

Testing for HPV infection as the first step in analysing cervical screening samples is practical and more sensitive than the current programme

More than 150,000 cervical screening samples were waiting to be tested by NHS laboratories across England last year, according to a report.

Cervical cancer rates are predicted to fall following the introduction of HPV primary screening this year.